MEDI5872
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI5872, covering 2019-03-19 to 2019-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome [Phase 2]